Diagnostic Test: 18F-FDG PET-MR ( DrugBank: 18F-FDG )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 8 | Huntington disease | 1 |
8. Huntington disease
Clinical trials : 229 / Drugs : 193 - (DrugBank : 60) / Drug target genes : 84 - Drug target pathways : 158
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04701580 (ClinicalTrials.gov) | January 14, 2020 | 5/1/2021 | Synaptic Density and Progression of Huntington's Disease. | Longitudinal Measurement of Synaptic Density to Monitor Progression of Huntington's Disease. | Huntington Disease | Diagnostic Test: 11C-UCB-J PET-CT;Diagnostic Test: 18F-FDG PET-MR | Universitaire Ziekenhuizen Leuven | NULL | Active, not recruiting | 20 Years | 75 Years | All | 33 | N/A | Belgium |